A small calorie surplus each day will lead to significant weight gain over time
Overall, about one in five (22%) adults who are not currently taking GLP-1 drugs (88% of the public) say they would be interested in taking a GLP-1 drug to lose weight, including just 7% who say they would be very interested. This rises to four in ten (43%) among adults who are not currently taking a GLP-1 but report being diagnosed as overweight or obese in the past five years, and about one in four (27%) among those who say they have been diagnosed with diabetes or heart disease
A Cost Comparison: Program Models To make this more concrete, let's break down the different ways you can access these treatments and what they generally entail
Nutritional Panel Ingredients 100% Acetyl L-Carnitine
Patients switching from Wegovy to orforglipron had a change of -0.1 kg versus a 9.4 kg gain for placebo
The convenience is obvious, but absorption rates can vary more than with injections, and some patients report that the oral formulation produces different side effect profiles compared to injectables